increased slightly between 2021 and 2024, but their uptake remained limited, with *ONLY 3%* of eligible patients having ever received a prescription during that period." "Low adoption and disparities in use likely reflect both system-level access barriers and patient-level demand, including narrow eligibility, limited insurance coverage, and financial considerations that may lead some individuals to forgo treatment after prescription." *NOTE: "did not include prescriptions from online-only pharmacies" and "products for diabetes were excluded" #obesity #medication #treatment #GLP1 #semaglutide #tirzepatide Sean C
[DOI] [78].Wadden TA, Bailey TS, Billings LK, et al
PlexusDx providers work with you throughout your treatment to track progress, adjust your dose if needed, and help you build habits that keep weight off once you reach your goal
The peptides hormonal relevance remains theoretical and based on its effects on upstream factors (inflammation, vascular health, gut integrity) rather than direct HPG axis stimulation
2024 Apr 1;78:89-94 Mechanism of action GLP-1 is an incretin hormone produced from the L cells of the small intestine that binds to the GLP-1 receptor (GLP-1R)
GLP-1s and Weight Loss Accessibility - Solving Todays High-Priced Drug Crisis GLP-1 medications continue to be significantly more affordable around the world than in the United States
.jpg)
